Finally… a second growth factor is on the market, the AUGMENT Bone Graft

Commentary:  Shame on the FDA!  If you replay the tape here you will find that the FDA approved the study protocol, the company then met the endpoints in the study, the FDA Panel approved it, and then the FDA denied it...  and then 4 years later approved it. This irrational behavior spooks the investment community.
Wright Medical Receives FDA Clearance for its Premarket Approval Application of its AUGMENT Bone Graft (HealthPointCapital)
Wright Medical announced that its BioMimetic subsidiary received approval from the FDA for its Premarket Approval Application (PMA) for its AUGMENT Bone Graft...